In the ever-evolving world of healthcare and surgical care, India’s isoflurane has emerged as a highly sought-after anesthetic agent in the global market. India’s rise as a reliable supplier reflects not only high volume but also quality, cost-effectiveness, and adherence to stringent international standards. This blog explores why Indian isoflurane exporters are gaining such prominence […]
Discover how India supplies 65–70% of WHO’s global vaccine needs. Explore India’s vaccine manufacturing power, exports, technology, and global healthcare leadership.
Learn about the future of pharma exports with technology, data and sustainability transforming global trade and driving exports of pharma products from India.
India’s pharmaceutical exports reached $30.4 billion in FY 2025. Learn what’s driving this growth—FDF exports, global demand, affordable generic drugs, emerging markets, and more.
AstraZeneca’s recent announcement of the launch of eculizumab in India marks a significant milestone in the treatment of rare diseases. For patients suffering from ultra-rare, life-threatening disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), this launch brings hope to the Indian medical community for access to long-awaited therapies. Regulatory Approval […]
Learn how to reduce the risk of heart attack naturally with the best heart health tips. Simple changes in lifestyle, diet and habits can protect your heart.
Learn how personalized medicine is transforming healthcare with tailored treatments, better outcomes and innovative solutions from S V Healthcare.
S V Healthcare is expanding into emerging pharma markets in 2025. Discover key opportunities, challenges, and strategies for success.
Biocon Biologics has received UK MHRA approval for denosumab biosimilars Vevzuo and Avefraxi, expanding its global biosimilar footprint in 2025.
